投票
发表于 2025-3-25 04:59:01
Daniel Ruiz-Vega,Louis Wehenkel,Damien Ernst,Alejandro Pizano-Martínez,Claudio R. Fuerte-Esquivel nuclear organization of specific CTs following fertilization. Our approach preserves the nuclear structure, and the acquired images allow full spatial analysis of interphase chromosome positioning and morphology across the cell cycle and during early development. This method will be useful in under
热情赞扬
发表于 2025-3-25 09:12:28
http://reply.papertrans.cn/83/8223/822289/822289_22.png
instructive
发表于 2025-3-25 12:29:17
http://reply.papertrans.cn/83/8223/822289/822289_23.png
obsession
发表于 2025-3-25 15:59:30
Jay Giri,Manu Parashar,Rene Avila-Rosales,Douglas Wilsonth present and future clinical strategies are considered. Individual chapters are devoted to the use of DNA hypomethylating agents and chromatin-modifying agents, and the treatment of hematologic malignancies and solid tumors by means of epigenetic agents is discussed in detail.978-3-662-51928-8978-3-642-38404-2
CLAIM
发表于 2025-3-25 23:36:57
Thierry Van Cutsem,Costas Vournasth present and future clinical strategies are considered. Individual chapters are devoted to the use of DNA hypomethylating agents and chromatin-modifying agents, and the treatment of hematologic malignancies and solid tumors by means of epigenetic agents is discussed in detail.978-3-662-51928-8978-3-642-38404-2
locus-ceruleus
发表于 2025-3-26 04:02:45
http://reply.papertrans.cn/83/8223/822289/822289_26.png
平常
发表于 2025-3-26 05:11:58
Tony B. Nguyen,M. A. Paith present and future clinical strategies are considered. Individual chapters are devoted to the use of DNA hypomethylating agents and chromatin-modifying agents, and the treatment of hematologic malignancies and solid tumors by means of epigenetic agents is discussed in detail.978-3-662-51928-8978-3-642-38404-2
craving
发表于 2025-3-26 11:50:52
http://reply.papertrans.cn/83/8223/822289/822289_28.png
arrogant
发表于 2025-3-26 16:20:57
Thomas J. Overbyeth present and future clinical strategies are considered. Individual chapters are devoted to the use of DNA hypomethylating agents and chromatin-modifying agents, and the treatment of hematologic malignancies and solid tumors by means of epigenetic agents is discussed in detail.978-3-662-51928-8978-3-642-38404-2
异端
发表于 2025-3-26 19:40:51
http://reply.papertrans.cn/83/8223/822289/822289_30.png